The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advisory bodies and committees (358)
- Scheduling (national classification system) (155)
- Prescription medicines (34)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicine safety (22)
- Therapeutic goods regulation (19)
- Medical devices safety (13)
- Manufacturing (11)
- Safety (10)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Registered complementary medicines (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Clinical trials (2)
- Compliance and enforcement hub (2)
- Import and export (2)
- Sunscreens (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
706 result(s) found, displaying 201 to 225
-
Meeting statementsMeeting statement from meeting 6 of the MDCWG.
-
Scheduling decisions (final)Notification of amendments to the Poisons Standard in relation to Delegate-only final decisions and New Chemical Entities (NCEs), April 2022
-
Meeting statementsTherapeutic Goods Advertising Consultative Committee, 21 March 2022 communique
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 31, 8 February 2022
-
PublicationsTGA's Half-yearly Performance Snapshot Report for July - December 2021 is now available.
-
PublicationsTGA publishes a Half-Yearly Performance Report (The Snapshot). The Snapshot provides statistical information on our performance highlights for the July to December period
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 30, 14 January 2022
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 29, 7 January 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 April 2022
-
PublicationsPrescription opioid tracking research
-
TGA laboratory testing reportsInformation on TGA laboratory testing of face masks and respirators
-
TGA laboratory testing reportsTest results of compliance testing against TGO110 of available and imported nicotine vaping products are now published on the TGA website.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 65, 10 February 2022
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement, Meeting 64, 9 December 2021
-
PublicationsMedicines Safety Update - Information for health professionals
-
Scheduling decisions (final)Public notice - Delegate-only decisions to amend the Poisons Standard and New Chemical Entities (NCEs)
-
Scheduling decisions (final)Final decision on proposed amendment to the Poisons Standard relating to sodium nitrite (Joint ACMS-ACCS #28, June 2021)
-
Meeting statementsAdvisory Committee on Vaccines, meeting 28, 22 December 2021
-
Meeting statementsAdvisory Committee on Vaccines, Meeting 27, 1 December 2021
-
Meeting statementsAdvisory Committee on Medicines, meeting statement now available
-
TGA laboratory testing reportsIn consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
PublicationsThe 2020-21 TGA Regulator Performance Framework Self-assessment (KPI) Report has now been published
-